Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rein Therapeutics (RNTX) Other Non-Current Liabilities (2024)

Rein Therapeutics (RNTX) has disclosed Other Non-Current Liabilities for 1 consecutive years, with $277000.0 as the latest value for Q4 2024.

  • On a quarterly basis, Other Non-Current Liabilities changed N/A to $277000.0 in Q4 2024 year-over-year; TTM through Dec 2024 was $277000.0, a N/A change, with the full-year FY2024 number at $277000.0, changed N/A from a year prior.
  • Other Non-Current Liabilities was $277000.0 for Q4 2024 at Rein Therapeutics, up from $116000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $277000.0 in Q4 2024 to a low of $116000.0 in Q2 2024.